Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

WATER IV PCa (AS Sub-study)

NCT: NCT07650448 · NOT_YET_RECRUITING

NCT IDNCT07650448
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2038-12
SponsorPROCEPT BioRobotics (INDUSTRY)
First posted
Last updated

Brief Summary

The WATER IV study is a multicenter, prospective, randomized clinical trial that aims to evaluate the safety and efficacy of Aquablation therapy in men with localized prostate cancer.

Frequently Asked Questions

What is WATER IV PCa (AS Sub-study)?

WATER IV PCa (AS Sub-study) is a clinical trial registered under NCT07650448. Current status: NOT_YET_RECRUITING.

What is the status of NCT07650448?

The current status of NCT07650448 (WATER IV PCa (AS Sub-study)) is: NOT_YET_RECRUITING.

When did WATER IV PCa (AS Sub-study) start?

WATER IV PCa (AS Sub-study) started on 2026-09.

Related Devices

K202961AquaBeam Robotic SystemProcept Biorobotics, Corporation K212835AquaBeam Robotic SystemProcept Biorobotics, Corporation K231024AquaBeam Robotic SystemProcept Biorobotics, Corporation K240200HYDROS Robotic System; HYDROS TRUS Probe; HYDROS HandpieceProcept Biorobotics K241952AQUABEAM Robotic System (AB2000)Procept Biorobotics

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑